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Performances of the Rapidec Carba NP test (bioMérieux) were evaluated for detection of all types of carbapenemases in Entero-
bacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. In less than 2 h after sample preparation, it showed a sen-
sitivity and speciﬁcity of 96%. This ready-to-use test is well adapted to the daily need for detection of carbapenemase producers
in any laboratory worldwide.
Multidrug resistance in Gram-negative bacteria is growing atan alarming rate (1). In this context, carbapenemase pro-
ducers are becoming extremely important (2, 3). Rapid detection
of carbapenemase producers provides critical information for an-
tibiotic stewardship and rapid implementation of outbreak con-
trol measures (3).
Few techniques are available for the rapid identiﬁcation of
carbapenemase producers (4) and include UV spectrophotom-
etry (5), matrix-assisted laser desorption ionization–time of
ﬂight (MALDI-TOF) technology (6–8), and molecular tech-
niques (9–12). These techniques have overall good sensitivities
and speciﬁcities but may require trained microbiologists, ex-
pensive equipment, and may be time-consuming and expen-
sive. In addition, molecular techniques may fail to detect un-
known carbapenemase genes or genes not included in the given
gene panel.
A rapid and biochemical detection of carbapenemase produc-
tion was recently proposed, namely, the Carba NP test, which is
based on the detection of the hydrolysis of the -lactam ring of
imipenem (13). The Carba NP test has been extensively validated
for the detection of carbapenemase producers in Enterobacteria-
ceae and Pseudomonas spp. (13–20), and a slightly modiﬁed ver-
sion of this test (CarbAcineto NP) has been developed for the
detection of carbapenemase-producing Acinetobacter spp. (21).
Here, we evaluated the performance of the Rapidec Carba NP test
(bioMérieux, La Balme-les-Grottes, France) from bacterial cul-
tures and compared its performance to those of the Carba NP test
(13) and the CarbAcineto NP test (21).
Performance of the Rapidec Carba NP test compared to that
of the Carba NP test. A total of 176 strains were used to evaluate
the performance of the Rapidec Carba NP test. They were from
various clinical origins (blood culture, urine, sputum, gut ﬂora),
of worldwide origin, and isolated from 2010 to 2014. These strains
had previously been characterized for their carbapenemase con-
tent at the molecular level (Table 1). This strain collection in-
cluded the most frequently acquired carbapenemases identiﬁed
worldwide, including those found in Enterobacteriaceae, Pseu-
domonas sp., and Acinetobacter sp. clinical isolates, and also rare
carbapenemases. Susceptibility testing was performed by deter-
mining MIC values using the Etest (bioMérieux) on Mueller-Hin-
ton agar plates at 37°C, and results were recorded according to
U.S. guidelines (CLSI) as updated in 2014 (22). A total of 98 iso-
lates producing all types of carbapenem-hydrolyzing -lactama-
ses were included, with 75 carbapenemase-negative strains either
carbapenem susceptible (n  52) or carbapenem resistant (per-
meability defects) (n 23) (Table 1).
Bacterial cultures were grown onto Mueller-Hinton E (MHE)
agar plates (bioMérieux). The Rapidec Carba NP test was per-
formed as recommended by the manufacturer. An inoculum cor-
responding to a full loop (10 l) of colonies taken from a culture
plate is mixed into the cell (the amount of bacteria is critical). Eye
reading of the plate is made after 30 min of incubation at 37°C and
then after 2 h, if necessary. A positive test corresponded to a red-
to-yellow or red-to-orange color change. This eye evaluation was
performed blindly by two technicianswho did not know about the
carbapenemase status of the strains.
The Rapidec Carba NP test showed excellent speciﬁcity and
sensitivity, allowing reliable detection of known carbapenemases
in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter
spp. Detection of the carbapenemase activity was successful for all
but four of the tested strains (Table 1), including a single GES-2-
producing P. aeruginosa isolate (23), a single OXA-23-producing
Acinetobacter baumannii isolate, a single OXA-40-producing
Acinetobacter pittii isolate, and a single Proteus mirabilis isolate
producing a chromosomally encodedOXA-23 (24). These isolates
were also all negative according to the home-made Carba NP test
(Table 1). The Rapidec Carba NP test showed excellent perfor-
mance with all bacterial species, including Acinetobacter spp. No
carbapenemase activity was detected among A. baumannii strains
resistant to carbapenems due to the overexpression of their intrin-
sic chromosomally encoded and therefore nontransferable OXA-
51-like enzyme (OXA-66) (Table 1). In contrast, production of
OXA-23 was detected in seven out of nine A. baumannii isolates
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(g/ml)30 min 2 h 30 min 2 h
Carbapenemase-negative strains
A. baumannii OXA-66 overexpression     16
A. baumannii OXA-66 overexpression     4
A. baumannii OXA-66 low-level expression     1
P. aeruginosa OXA-28     2
E. coli OXA-30     0.06
E. cloacae OXA-163 CTX-M-15     0.5
E. coli ACC-1     0.25
K. pneumoniae ACT-1     0.5
P. aeruginosa OprD mutant, MexAB, AmpC     64
Citrobacter freundii AmpC ESBL porin deﬁciency     32
E. cloacae AmpC ESBL porin deﬁciency     128
E. cloacae AmpC ESBL porin deﬁciency     256
E. coli AmpC ESBL porin deﬁciency     16
K. pneumoniae AmpC ESBL porin deﬁciency     32
Enterobacter aerogenes AmpC porin deﬁciency     32
E. cloacae AmpC porin deﬁciency     64
E. cloacae AmpC porin deﬁciency     8
E. coli AmpC porin deﬁciency     8
E. coli ESAC porin deﬁciency     8
Hafnia alvei AmpC porin deﬁciency     16
Klebsiella oxytoca AmpC porin deﬁciency     4
K. pneumoniae AmpC porin deﬁciency     32
K. pneumoniae AmpC porin deﬁciency     64
M. morganii AmpC porin deﬁciency NIb NI   64
Serratia marcescens ESAC porin deﬁciency     0.25
E. aerogenes ESBL porin deﬁciency     0.12
E. cloacae ESBL porin deﬁciency     0.5
E. coli ESBL porin deﬁciency     0.12
K. oxytoca ESBL porin deﬁciency     0.12
K. pneumoniae ESBL porin deﬁciency     0.06
K. pneumoniae ESBL porin deﬁciency     0.25
P. mirabilis ESBL porin deﬁciency     0.12
E. cloacae AmpC TEM-1 CTX-M-15     0.25
E. cloacae AmpC TEM-1 OXA-1     0.5
A. baumannii ESAC overexpression     2
A. baumannii AmpC overexpression     0.5
P. aeruginosa AmpC overexpression     0.5
E. coli ACC-1     0.25
E. coli CMY-2     0.5
A. baumannii Wild type     0.25
A. baumannii Wild type     0.5
E. cloacae Wild type     0.06
E. coli Wild type     0.06
P. aeruginosa Wild type     0.12
P. aeruginosa BEL-1     1
P. mirabilis CMY-2     1
P. vulgaris CMY-2     2
E. coli CTX-M-1     0.12
P. mirabilis CTX-M-1     0.5
E. coli CTX-M-15     0.06
K. pneumoniae CTX-M-15     0.12
E. cloacae CTX-M-15 NI NI NI NI 0.06
E. coli CTX-M-15 SHV-12     0.06
K. pneumoniae CTX-M-15 SHV-12     0.12
K. pneumoniae CTX-M-15 SHV-28     0.06
C. freundii CTX-M-3     0.12
E. aerogenes CTX-M-3     0.12
P. aeruginosa GES-9     0.25
K. pneumoniae GES-1     0.12
K. pneumoniae DHA-1     0.25
A. baumannii ESAC     1




















(g/ml)30 min 2 h 30 min 2 h
A. baumannii ESAC     0.5
E. coli ESAC     0.25
S. marcescens ESAC     0.06
K. pneumoniae FOX-5     0.25
A. baumannii PER-1     0.25
E. cloacae PER-1     0.12
A. baumannii PER-2     0.5
K. pneumoniae SHV-2a     0.12
K. pneumoniae SHV-38     0.25
C. freundii TEM-24     0.12
E. cloacae TLA-1     0.25
E. coli VEB-1 OXA-10 TEM-1     0.06
P. aeruginosa VEB-1 OXA-10 TEM-1     0.06
Acinetobacter johnsonii VEB-1 SCO-1     0.12
Carbapenemase-positive strains
P. aeruginosa FIM-1     128
Pseudomonas ﬂuorescens BIC-1     128
P. aeruginosa GES-2     16
P. aeruginosa GES-5     32
E. cloacae GIM-1     1
P. aeruginosa GIM-1     64
E. cloacae IMI-2     256
S. marcescens SME-1     16
P. aeruginosa SPM-1     64
P. aeruginosa IMP-1     64
S. marcescens IMP-1     32
P. aeruginosa IMP-10     128
P. aeruginosa IMP-13     4
P. aeruginosa IMP-13     8
C. freundii KPC-2 TEM-1     1
E. cloacae KPC-2 TEM-1 CTX-M-15     2
K. pneumoniae KPC-2 SHV-1 TEM-1 CTX-M-15     4
K. pneumoniae KPC-2 SHV-1 TEM-1 OXA-9     8
P. aeruginosa KPC-2     256
E. coli KPC-3 OXA-9     1
K. pneumoniae KPC-3 SHV-11 TEM-1 OXA-9     16
A. baumannii NDM-1     16
A. baumannii NDM-1 TEM-1     32
A. baumannii NDM-1     8
A. baumannii NDM-2     32
A. baumannii NDM-1     16
E. cloacae NDM-1     8
E. cloacae NDM-1 CTX-M-15     4
E. coli NDM-1 CTX-M-15 TEM-1     4
E. coli NDM-1 OXA-1 TEM-1 CMY-30     16
E. coli NDM-1 CTX-M-15 TEM-1     4
K. pneumoniae NDM-1 CTX-M-15 TEM-1 OXA-1     8
K. pneumoniae NDM-1 CTX-M-15 TEM-1 CMY-16     2
P. mirabilis NDM-1     16
P. mirabilis NDM-1 OXA-1 TEM-1 CMY-16     8
P. aeruginosa NDM-1     64
E. coli NDM-4 CTX-M-15 TEM-1 OXA-1     8
K. pneumoniae NDM-4 CTX-M-15 SHV-11     16
E. coli NDM-5 CTX-M-15 TEM-1     4
E. coli NDM-7 CTX-M-15 TEM-1     32
A. baumannii OXA-143     128
C. freundii OXA-162     4
E. coli OXA-181 CTX-M-15     4
K. pneumoniae OXA-181 CTX-M-15 TEM-1 SHV-11     16
E. coli OXA-204 CTX-M-15 TEM-1 CMY-2     0.5
E. coli OXA-204 CTX-M-15 TEM-1 CMY-4     0.5











tested, which is important considering the large dissemination of
OXA-23 producers worldwide (25).
False-positive results were obtained with very few isolates and
included two A. baumannii isolates overproducing AmpCs (one
an extended-spectrum AmpC [ESAC]) (26) and a single Proteus
vulgaris isolate producing a plasmid-encoded CMY-2 (known to
possess very weak carbapenemase activity [27]).










(g/ml)30 min 2 h 30 min 2 h
P. mirabilis OXA-204     4
A. baumannii OXA-23 TEM-1     32
A. baumannii OXA-23 PER-1     16
A. baumannii OXA-23 PER-7     8
A. baumannii OXA-23 GES-11     16
A. baumannii OXA-23     32
A. baumannii OXA-23     8
P. mirabilis OXA-23     0.25
A. baumannii OXA-23NDM-1     512
A. baumannii OXA-23OXA-40     512
K. pneumoniae OXA-232 CTX-M-15 OXA-1 TEM-1     128
A. baumannii OXA-40     64
A. baumannii OXA-40 TEM-1     32
Acinetobacter pittii OXA-40     16
C. freundii OXA-48 SHV-12 TEM-1     16
E. aerogenes OXA-48 TEM-1     8
E. aerogenes OXA-48 TEM-1 SHV-12     4
E. aerogenes OXA-48     8
E. cloacae OXA-48 TEM-1     2
E. cloacae OXA-48 TEM-1 CTX-M-15     4
E. cloacae OXA-48     16
Enterobacter hormaechei OXA-48     8
E. coli OXA-48 TEM-1     4
E. coli OXA-48 CTX-M-15     8
E. coli OXA-48 CTX-M-15 TEM-1     8
E. coli OXA-48 CTX-M-14 NI NI NI NI 16
E. coli OXA-48     2
K. pneumoniae OXA-48 SHV-28   NI NI 4
K. pneumoniae OXA-48 SHV-28 CTX-M-15 TEM-1     8
K. pneumoniae OXA-48 SHV-1 TEM-1     8
K. pneumoniae OXA-48 SHV-11 SHV-2a OXA-47 TEM-1 OXA-1     16
S. marcescens OXA-48     16
S. marcescens OXA-48 CTX-M-15     4
A. baumannii OXA-58     32
A. baumannii OXA-58     64
Acinetobacter haemolyticus OXA-58     128
E. aerogenes VIM-1     2
E. cloacae VIM-1     1
K. pneumoniae VIM-1 SHV-5     2
K. pneumoniae VIM-1 SHV-12     4
P. aeruginosa VIM-1     16
P. aeruginosa VIM-1     128
Pseudomonas putida VIM-1     256
C. freundii VIM-2 TEM-1     8
P. mirabilis VIM-2     2
P. aeruginosa VIM-2     256
P. ﬂuorescens VIM-2     256
P. putida VIM-2     128
Pseudomonas stutzeri VIM-2     64
S. marcescens VIM-2 CTX-M-15     64
Citrobacter murliniae VIM-4     16
K. pneumoniae VIM-4 CTX-M-15 TEM-1 SHV-11     8
P. aeruginosa VIM-4     128
P. putida VIM-5     256
a ESBL, extended-spectrum -lactamase; ESAC, AmpC with extended hydrolytic activity toward broad-spectrum cephalosporins. Carbapenemases are indicated in bold.











isolate gave a negative result, which is in accordance with the fact
that this OXA-48 variant is known to lack signiﬁcant carbapen-
emase activity (28).
Interpretation of the Rapidec Carba NP test.
Inmost cases, positive results obtainedwith theRapidecCarbaNP
test corresponded to a frank color change from red to yellow (Fig-
ure 1). For the class A and class B carbapenemase producers, the
color change was always obtained in 10 min. For the class D
-lactamases, the color change was obtained in30 min. Extend-
ing the duration of visual inspection to 2 h did not provide any
additional value to the test.
Overall, 1.7% of the isolates gave noninterpretable results,
meaning that those strains generated an acidiﬁcation of the reac-
tion regardless of the presence of the carbapenem substrate.
Among them, there was a single OXA-48-producing Escherichia
coli isolate and a single CTX-M-15-producing E. cloacae isolate.
Similarly, noninterpretable results were obtained with those two
strains when using the home-made Carba NP test. Another non-
interpretable result was obtained with an OXA-48-producing iso-
late using the Carba NP, but it was interpretable and positive with
the Rapidec Carba NP test. Conversely, a noninterpretable result
was obtained with the Rapidec Carba NP test but not with the
Carba NP when testing a carbapenem-resistant but carbapen-
emase-negative Morganella morganii isolate overexpressing its
chromosomal AmpC and showing permeability defect.
Interestingly, faster results were obtained with some isolates
regardless of their carbapenem MIC levels. The fastest results were
always obtained with class A carbapenemase producers (most of
the time within 5 to 10 min), then with class B carbapenemase
producers (10 to 15 min), and followed by class D carbapenemase
producers (20 to 30 min).
Performance of the Rapidec Carba NP test for identiﬁcation
of patients colonized with carbapenemase producers. In order
to evaluate whether the Rapidec Carba NP test may be useful for
screening carbapenemase producers from colonized patients,
stool samples that were negative for carbapenemase-producing
bacteria were spiked with several carbapenemase-producing
strains (n  30). An inoculum of 105 CFU/g of each strain was
added to each stool sample. An average of ca. 20mg of spiked stool
was tested to simulate the feces quantity of a rectal swab. Spiked
stool samples were then cultured onto chromID OXA-48 plates
(selection of OXA-48-like producers) (bioMérieux) and chromID
Carba plates (selection of all the other carbapenemase producers)
(bioMérieux). All colonies tested positive with the Rapidec Carba
NP test within 30 min regardless of the species tested. The color of
the colonies obtained on the chromogenic screening plates (red,
blue, green, etc.) did not interfere with the interpretation of the
RapidecCarbaNP test.Neither the sensitivity nor the speciﬁcity of
the test was modiﬁed.
Rapidec Carba NP test and carbapenemase-producing
strains presenting a mucoid phenotype. A special preparation of
the lysate was made for mucoid isolates in order to evaluate
whether the mucoid phenotype of speciﬁc strains might interfere
with the results of the Carba NP test. A 10-l full loop of mucoid
colonies was resuspended in 100 l of suspension solution in an
Eppendorf tube in which two 3-mm large glass beads were added
(VWR International, Nyon, Switzerland). This solution was vor-
texed for 1 min, and the 100-l supernatant was taken as a sample
for further testing following the classical protocol as mentioned
above. A total of 18 strains were tested, including seven carbapen-
emase-producing isolates, three carbapenem-resistant but car-
bapenemase-negative isolates, and 11 wild-type Klebsiella pneu-
moniae isolates without acquired resistance mechanisms to
-lactams. All carbapenemase-producing isolates tested positive,
and no false positivity or noninterpretable results were observed.
In conclusion, the results obtained here highlight that the
RapidecCarbaNP test is very sensitive and speciﬁc for detection of
carbapenemases in clinically signiﬁcant Gram-negative bacteria.
The use of the Rapidec Carba NP test may contribute to the iden-
tiﬁcation of carbapenemase producers and improve infection
control.
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